Sulfasalazine attenuates evading anticancer response of CD133-positive hepatocellular carcinoma cells

Abstract

Background

CD133-positive cells in hepatocellular carcinoma (HCC) display cancer stem cell (CSC)-like properties in addition to resistance to chemotherapeutic agents and radiation that is ionizing but, their function remains unknown. In this paper, we identified a hitherto unknown procedure to overcome CD133-induced resistance to therapy that is anticancer.

Techniques

We applied a alternate approach to enrich the CD133-positive HCC populace by manipulating 3D culture conditions. Body’s defence mechanism against reactive oxygen species (ROS) in CSC spheroids had been assessed by fluorescence image-based phenotypic screening system. Further, we learned the result of sulfasalazine on ROS defense system and synergistic healing efficacy of anticancer therapies both in culture plus in vivo HCC xenograft mouse model.

Outcomes

Right Here, we unearthed that oxidative anxiety increase CD133 phrase in HCC and increased CD133 phrase enhanced the ability of the defense system against ROS, and thereby play a role that is central opposition to liver cancer therapy.Read More